The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Polymeric nanoparticles‐based topical delivery systems for the treatment of dermatological diseases
Open accessAbstract
Human skin not only functions as a permeation barrier (mainly because of the stratum corneum layer) but also provides a unique delivery pathway for therapeutic and other active agents. These compounds penetrate via intercellular, intracellular, and transappendageal routes, resulting in topical delivery (into skin strata) and transdermal delivery (to subcutaneous tissues and into the systemic circulation). Passive and active permeation enhancement methods have been widely applied to increase the cutaneous penetration. The pathology, pathogenesis, and topical treatment approaches of dermatological diseases, such as psoriasis, contact dermatitis, and skin cancer, are then discussed. Recent literature has demonstrated that nanoparticles‐based topical delivery systems can be successful in treating these skin conditions. The studies are reviewed starting with the nanoparticles based on natural polymers especially chitosan, followed by those made of synthetic, degradable (aliphatic polyesters), and nondegradable (polyacrylates) polymers; emphasis is given to nanospheres made of polymers derived from naturally occurring metabolites, the tyrosine‐derived nanospheres (TyroSpheres™). In summary, the nanoparticles‐based topical delivery systems combine the advantages of both the nanosized drug carriers and the topical approach, and are promising for the treatment of skin diseases. For the perspectives, the penetration of ultra‐small nanoparticles (size smaller than 40 nm) into skin strata, the targeted delivery of the encapsulated drugs to hair follicle stem cells, and the combination of nanoparticles and microneedle array technologies for special applications such as vaccine delivery are discussed. WIREs Nanomed Nanobiotechnol 2013, 5:205–218. doi: 10.1002/wnan.1211 This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Scheuplein, R. J., & Blank, I. H. (1971) · Physiological Reviews · doi:10.1152/physrev.1971.51.4.702 · Cited by 1,398
Dermatology in General Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_2 · Cited by 1,237
Review: Ultraviolet radiation and skin cancer
Narayanan, D. L., Saladi, R. N., & Fox, J. L. (2010) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04474.x · Cited by 1,184
Rapid translocation of nanoparticles from the lung airspaces to the body
Choi, H. S., Ashitate, Y., Lee, J. H., Kim, S. H., Matsui, A., Insin, N., Bawendi, M. G., Semmler-Behnke, M., Frangioni, J. V., & Tsuda, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1696 · Cited by 648
Skin penetration and distribution of polymeric nanoparticles
Alvarez-Román, R., Naik, A., Kalia, Y. N., Guy, R. H., & Fessi, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.015 · Cited by 626
Challenges and Opportunities in dermal/transdermal Delivery
Paudel, K. S., Milewski, M., Swadley, C. L., Brogden, N. K., Ghosh, P., & Stinchcomb, A. L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.16 · Cited by 616
Passive skin penetration enhancement and its quantification in vitro
Moser, K. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00166-7 · Cited by 553
Epithelial Stem Cells: A Folliculocentric View
Cotsarelis, G. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700376 · Cited by 553
Getting under the skin: the immunogenetics of psoriasis
Bowcock, A. M., & Krueger, J. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1689 · Cited by 484
Physical chemical analysis of percutaneous absorption process from creams and ointments.
Higuchi, T. (1960) · Medical Entomology and Zoology · Cited by 464
Polymeric Nanoparticles, Nanospheres and Nanocapsules, for Cutaneous Applications
Guterres, S. S., Alves, M. P., & Pohlmann, A. R. (2007) · Drug Target Insights · doi:10.1177/117739280700200002 · Cited by 461
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905998106 · Cited by 453
Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation
Zheng, D., Giljohann, D. A., Chen, D. L., Massich, M. D., Wang, X.-Q., Iordanov, H., Mirkin, C. A., & Paller, A. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118425109 · Cited by 409
Transdermal delivery of desmopressin using a coated microneedle array patch system
Cormier, M., Johnson, B. L., Ameri, M., Nyam, K., LIBIRAN, L., Zhang, D. D., & Daddona, P. E. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.003 · Cited by 388
Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications.
Guterres, S. S., Alves, M. P., & Pohlmann, A. R. (2007) · PubMed · Cited by 302
Transdermal delivery of mixnoxidil with block copolymer nanoparticles
Shim, J., Seok Kang, H., Park, W.-S., Han, S.-H., Kim, J., & Chang, I.-S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.028 · Cited by 300
Allergic and irritant contact dermatitis
Nosbaum, A., Vocanson, M., Rozieres, A., Hennino, A., & Nicolas, J.-F. (2009) · European Journal of Dermatology · doi:10.1684/ejd.2009.0686 · Cited by 255
Enhancement of Topical Delivery from Biodegradable Nanoparticles
Alvarez-Rom#x00E1;n, R., Naik, A., Kalia, Y. N., Guy, R. H., & Fessi, H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045235.86197.ef · Cited by 248
Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use
Vandervoort, J., & Ludwig, A. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00187-5 · Cited by 245
Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs
Shah, P. P., Desai, P. R., Patel, A. R., & Singh, M. S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.011 · Cited by 229
Retinol-encapsulated low molecular water-soluble chitosan nanoparticles
KIM, D., JEONG, Y., CHOI, C., ROH, S., KANG, S., JANG, M., & NAH, J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.040 · Cited by 226
Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery
Zhai, G., Guo, Tan, & Liu (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s22411 · Cited by 218
Percutaneous Penetration Enhancers: Overview
Zhai, H., Maibach, H., & Thong, H.-Y. (2007) · Dermatotoxicology, Seventh Edition · doi:10.1201/9781420009774.ch5 · Cited by 216
Batheja, P., Sheihet, L., Kohn, J., Singer, A. J., & Michniak-Kohn, B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.005 · Cited by 197
Self-citationde la Fuente, M., Seijo, B., & Alonso, M. J. (2008) · Gene Therapy · doi:10.1038/gt.2008.16 · Cited by 194
Naldi, L., & Griffiths, C. E. M. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06563.x · Cited by 183
Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection
Alvarez-Román, R. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00188-6 · Cited by 181
Two-Layered Dissolving Microneedles for Percutaneous Delivery of Peptide/Protein Drugs in Rats
Fukushima, K., Ise, A., Morita, H., Hasegawa, R., Ito, Y., Sugioka, N., & Takada, K. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0097-7 · Cited by 171
Turos, E., Shim, J.-Y., Wang, Y., Greenhalgh, K., Reddy, G. S. K., Dickey, S., & Lim, D. V. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.098 · Cited by 169
Microneedle mediated delivery of nanoparticles into human skin
Coulman, S. A., Anstey, A., Gateley, C., Morrissey, A., McLoughlin, P., Allender, C., & Birchall, J. C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.040 · Cited by 166
Misbehaving macrophages in the pathogenesis of psoriasis
Clark, R. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29441 · Cited by 158
Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin
Şenyiğit, T., Sonvico, F., Barbieri, S., Özer, Ö., Santi, P., & Colombo, P. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.013 · Cited by 157
Kanjilal, S., Strom, S. S., Clayman, G. L., Weber, R. S., El‐Naggar, A. K., Kapur, V., Cummings, K. K., HILL, L. A., Spitz, M. R., & Kripke, M. L. (1995) · PubMed · Cited by 148
Harvey, A., Kaestner, S. A., Sutter, D. E., Harvey, N. G., Mikszta, J. A., & Pettis, R. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0123-9 · Cited by 148
Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon
Chuah, L., Billa, N., Roberts, C. J., Burley, J., & Manickam, S. (2011) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2011.640688 · Cited by 142
Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles
Zhang, W., Gao, J., Quan-gang, Z., Zhang, M., Ding, X., Wang, X., Hou, X., Fan, W., Ding, B., & Wu, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.037 · Cited by 129
Quan, F., Kim, Y., Compans, R. W., Prausnitz, M. R., & Kang, S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.125 · Cited by 117
Shahnaz, G., Vetter, A., Barthelmes, J., Rahmat, D., Laffleur, F., Iqbal, J., Perera, G., Schlocker, W., Dünnhaput, S., Augustijns, P., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.02.044 · Cited by 116
Design of Self-Assembling Peptides and Their Biomedical Applications
Liu, J., & Zhao, X. (2011) · Nanomedicine · doi:10.2217/nnm.11.142 · Cited by 112
Development of paclitaxel-TyroSpheres for topical skin treatment
Kilfoyle, B. E., Sheihet, L., Zhang, Z., Laohoo, M., Kohn, J., & Michniak‐Kohn, B. B. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.021 · Cited by 101
Self-citationHasanovic, A., Zehl, M., Reznicek, G., & Valenta, C. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.12.0004 · Cited by 98
Review Paper: Preclinical Models of Psoriasis
Danilenko, D. M. (2008) · Veterinary Pathology · doi:10.1354/vp.45-4-563 · Cited by 94
(2002) · CRC Press eBooks · doi:10.1201/9780203909683 · Cited by 88
Wu, X., Price, G. J., & Guy, R. H. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9001188 · Cited by 87
Tsujimoto, H., Hara, K., Tsukada, Y., Huang, C. C., Kawashimà, Y., Arakaki, M., Okayasu, H., Mimura, H., & Miwa, N. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.06.057 · Cited by 74
Andersen, K. E., Benezra, C., Burrows, D., Camarasa, J. G., Dooms‐Goossens, A., DUCOMBS, G., Frosch, P. J., Lachapelle, J. M., Lahti, A., Menné, T., et al. (1987) · Contact Dermatitis · doi:10.1111/j.1600-0536.1987.tb01382.x · Cited by 74
Sheihet, L., Piotrowska, K., Dubin, R. A., Kohn, J., & Devore, D. I. (2007) · Biomacromolecules · doi:10.1021/bm060860t · Cited by 70
In vivo studies of polyacrylate nanoparticle emulsions for topical and systemic applications
Greenhalgh, K., & Turos, E. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.07.004 · Cited by 60
Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery
Özbaş‐Turan, S., & Akbuğa, J. (2011) · Drug Delivery · doi:10.3109/10717544.2010.544688 · Cited by 57
Lee, R. W., Shenoy, D. B., & Sheel, R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-8155-2025-2.10002-2 · Cited by 52
Role of Imiquimod in Skin Cancer Treatment
Urosevic, M., & Dummer, R. (2004) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200405060-00010 · Cited by 50
Sheihet, L., Garbuzenko, O. B., Bushman, J. S., Gounder, M. K., Minko, T., & Kohn, J. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.11.017 · Cited by 44
Patel, M. M., Jain, S. K., Yadav, A. K., Gogna, D., & Agrawal, G. P. (2006) · Drug Delivery · doi:10.1080/10717540500398175 · Cited by 42
Akomeah, F. K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.06.005 · Cited by 31
Cited by
Nanoparticles and nanofibers for topical drug delivery
Goyal, R., Macri, L. K., Kaplan, H. M., & Kohn, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.049 · Cited by 590
Polymeric nanoparticles: the future of nanomedicine
Banik, B. L., Fattahi, P., & Brown, J. L. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1364 · Cited by 485
Nanocarriers for drug delivery applications
Chamundeeswari, M., Jeslin, J., & Verma, M. L. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-018-00841-1 · Cited by 444
Skin cancer and new treatment perspectives: A review
Simões, M. C. F., Sousa, J. J. S., & Pais, A. A. C. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.001 · Cited by 414
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z.-S., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 365
Metadata
- Authors
- Zhang, Z., Tsai, P., Ramezanli, T., & Michniak‐Kohn, B. B.
- Venue
- WIREs Nanomedicine and Nanobiotechnology
- Publisher
- Wiley
- Published
- 2013-02-05
- Volume
- 5
- Issue
- 3
- Pages
- 205-218
- ISSN
- 1939-0041 (ISSN-L)
- 1939-5116
- OpenAlex
- W1981636071
- Cited by
- 357
- References
- 57
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.